C48.0 ICD-10-CM Code: Malignant neoplasm of retroperitoneum
C48.0 maps to CMS-HCC V28 20. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · free HCC coding tools
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of mesothelial and soft tissue (C45-C49)
C48.0
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceMalignant neoplasm of retroperitoneum
Cancer that starts in the retroperitoneum, which is the space behind the abdominal lining. This malignant tumor develops in the tissue layer at the back of the abdomen.

Buddy Insight
Malignant neoplasm of the retroperitoneum represents a severe cancer classification encompassing retroperitoneal sarcomas, which are among the most challenging abdominal malignancies to manage.
CMS-HCC V28
MappedHCC 20
Coefficient HCC 20: 1.136 (Community Non-Dual Aged (CNA))
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
MappedHCC 009
Code-level coefficient reference
ESRD/PACE
MappedHCC 9
Code-level coefficient reference
RXHCC
MappedHCC 22
Code-level coefficient reference
Code Book Path
Inclusion Terms
OfficialNo inclusion terms are included in this display for C48.0. Check the code and parent instructions in the Code Book.
Excludes 2
OfficialNo Excludes 2 notes are included in this display for C48.0. Check the code and parent instructions in the Code Book.
Related Codes
Includes
OfficialNo Includes notes are included in this display for C48.0. Check the code and parent instructions in the Code Book.
Excludes 1
Official- Kaposi's sarcoma of connective tissue (C46.1)Inherited from C48
- mesothelioma (C45.-)Inherited from C48
Code First
OfficialNo Code First sequencing instructions are included in this display for C48.0. Check the code and parent instructions in the Code Book.
Use Additional
OfficialNo Use Additional Code instructions are included in this display for C48.0. Check the code and parent instructions in the Code Book.
Code Also
OfficialNo Code Also instructions are included in this display for C48.0. Check the code and parent instructions in the Code Book.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is C48.0 an HCC code?
Yes. C48.0 (Malignant neoplasm of retroperitoneum) maps to HCC 20, Lung and Other Severe Cancers under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 1.136. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.
Coder answer: C48.0 is billable and maps to V28 HCC 20, Lung and Other Severe Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- C48.0
- Description
- Malignant neoplasm of retroperitoneum
- HCC (V28)
- HCC 20 — Lung and Other Severe Cancers
- RAF reference coefficient
- 1.136
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work C48.0 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT review for C48.0
For C48.0, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
C48.0 is the ICD-10-CM diagnosis code for malignant neoplasm of retroperitoneum. Cancer that starts in the retroperitoneum, which is the space behind the abdominal lining. This malignant tumor develops in the tissue layer at the back of the abdomen. C48.0 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of mesothelial and soft tissue (c45-c49).
Under the CMS-HCC V28 risk adjustment model, C48.0 maps to Lung and Other Severe Cancers (HCC 20) with a source-labeled community, non-dual, aged reference coefficient of 1.136. No V24 mapping is shown for C48.0; use the applicable model and payment year when reviewing the V28 mapping. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.
Retroperitoneum is distinct from peritoneum; do not confuse with C48.1. For C48.0, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for C48.0 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Retroperitoneum is distinct from peritoneum; do not confuse with C48.1
- •Common sites include retroperitoneal sarcomas; document histology and specific location when available
Clinical Significance
Malignant neoplasm of the retroperitoneum represents a severe cancer classification encompassing retroperitoneal sarcomas, which are among the most challenging abdominal malignancies to manage.
Documentation Requirements
- ✓Pathology confirming malignant neoplasm with retroperitoneal origin
- ✓Histological subtype (liposarcoma, leiomyosarcoma, undifferentiated pleomorphic sarcoma, etc.)
- ✓Tumor size and imaging (CT/MRI) documenting extent and organ involvement
- ✓Surgical resection status and margin assessment
- ✓Distinction from retroperitoneal metastasis (secondary malignancy would use C78 codes)
Commonly Confused Codes
- •C48.1 (Malignant neoplasm of specified parts of peritoneum): peritoneal, not retroperitoneal location
- •C47.4 (Malignant neoplasm of peripheral nerves of abdomen): nerve-origin abdominal tumor
- •C49.4 (Malignant neoplasm of connective/soft tissue of abdomen): abdominal wall soft tissue, not retroperitoneum
- •C78.6 (Secondary malignant neoplasm of retroperitoneum): metastatic disease, not primary retroperitoneal cancer

